Ratings Humanica

Equities

HUMAN

TH8335010006

End-of-day quote Thailand S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
10.7 ^THB	-0.93%		-6.14%	+1.90%

Apr. 25	Humanica Public Company Limited Approves Dividend for the Operating Period from July 1, 2023 to December 31, 2023, Payable on May 23, 2024	CI
Feb. 28	Humanica Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

With a 2024 P/E ratio at 26.1 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The company's "enterprise value to sales" ratio is among the highest in the world.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
HUMANICA	+1.90%	251M	-
ORACLE CORPORATION	+10.49%	320B	B-
SAP SE	+22.17%	213B	B+
SERVICENOW, INC.	+2.08%	148B	B
CONSTELLATION SOFTWARE INC.	+9.95%	56.08B	D+
HUBSPOT, INC.	+9.58%	32.39B	B+
FAIR ISAAC CORPORATION	-1.80%	28.25B	C+
MICROSTRATEGY INCORPORATED	+104.71%	22.8B	D+
WISETECH GLOBAL LIMITED	+23.11%	20.04B	B-
SAGE GROUP PLC	-1.15%	14.59B	B-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes